HU9303314D0 - Process for producing elasteze- and catepsin-d-inhibitors - Google Patents

Process for producing elasteze- and catepsin-d-inhibitors

Info

Publication number
HU9303314D0
HU9303314D0 HU9303314A HU9303314A HU9303314D0 HU 9303314 D0 HU9303314 D0 HU 9303314D0 HU 9303314 A HU9303314 A HU 9303314A HU 9303314 A HU9303314 A HU 9303314A HU 9303314 D0 HU9303314 D0 HU 9303314D0
Authority
HU
Hungary
Prior art keywords
inhibitors
elasteze
catepsin
producing
cathepsin
Prior art date
Application number
HU9303314A
Other languages
English (en)
Other versions
HU217612B (hu
HUT65140A (en
Inventor
Michael Richard Angelastro
Philippe Bey
Niall S Doherty
Michael J Janusz
Shujaath Mehdi
Norton Paul Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of HU9303314D0 publication Critical patent/HU9303314D0/hu
Publication of HUT65140A publication Critical patent/HUT65140A/hu
Publication of HU217612B publication Critical patent/HU217612B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Polymerisation Methods In General (AREA)
  • Transceivers (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vehicle Body Suspensions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9303314A 1991-05-23 1992-04-21 Eljárás elasztáz és katepszin G inhibitor hatású peptidek előállítására HU217612B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23
PCT/US1992/003288 WO1992020357A1 (en) 1991-05-23 1992-04-21 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation

Publications (3)

Publication Number Publication Date
HU9303314D0 true HU9303314D0 (en) 1994-03-28
HUT65140A HUT65140A (en) 1994-04-28
HU217612B HU217612B (hu) 2000-03-28

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9303314A HU217612B (hu) 1991-05-23 1992-04-21 Eljárás elasztáz és katepszin G inhibitor hatású peptidek előállítására

Country Status (17)

Country Link
US (1) US5510333A (hu)
EP (1) EP0587799B1 (hu)
JP (1) JP3442075B2 (hu)
AT (1) ATE181925T1 (hu)
AU (1) AU655301B2 (hu)
DE (1) DE69229552T2 (hu)
DK (1) DK0587799T3 (hu)
ES (1) ES2136091T3 (hu)
FI (1) FI935172A0 (hu)
GR (1) GR3031005T3 (hu)
HU (1) HU217612B (hu)
IL (1) IL101925A (hu)
NO (1) NO934218L (hu)
NZ (1) NZ242807A (hu)
PT (1) PT100517B (hu)
WO (1) WO1992020357A1 (hu)
ZA (1) ZA923602B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
EP0635028B1 (en) * 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
CA2137832C (en) * 1992-06-12 2000-09-26 Dennis J. Hoover Inhibitors of angiotensin i chymase(s) including human heart chymase
JP3721538B2 (ja) * 1994-06-02 2005-11-30 メレル ファーマスーティカルズ インコーポレイテッド エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6608030B1 (en) * 1996-04-22 2003-08-19 Brigham & Women's Hospital, Inc. Suppression of immune response via inhibition of cathepsin S
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´，α´，α´−トリハロケトン誘導体、α−アミノ−α´，α´，α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
EP4165037A4 (en) 2020-06-10 2024-07-03 Aligos Therapeutics Inc ANTIVIRAL COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS, PICORNAVIRUS AND NOROVIRUS INFECTIONS
IL309732A (en) 2021-07-09 2024-02-01 Aligos Therapeutics Inc Antiviral compounds
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
CA1341029C (en) * 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (en) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin analogs
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
ES2136091T3 (es) 1999-11-16
EP0587799B1 (en) 1999-07-07
PT100517B (pt) 1999-06-30
IL101925A (en) 1996-03-31
FI935172A (fi) 1993-11-22
DK0587799T3 (da) 1999-11-22
GR3031005T3 (en) 1999-12-31
AU2184192A (en) 1992-12-30
HU217612B (hu) 2000-03-28
HUT65140A (en) 1994-04-28
JPH06508355A (ja) 1994-09-22
NO934218D0 (no) 1993-11-22
EP0587799A4 (en) 1995-06-14
DE69229552T2 (de) 1999-12-23
NO934218L (no) 1993-11-22
AU655301B2 (en) 1994-12-15
JP3442075B2 (ja) 2003-09-02
EP0587799A1 (en) 1994-03-23
NZ242807A (en) 1994-07-26
US5510333A (en) 1996-04-23
FI935172A0 (fi) 1993-11-22
IL101925A0 (en) 1992-12-30
PT100517A (pt) 1993-09-30
WO1992020357A1 (en) 1992-11-26
ZA923602B (en) 1993-02-24
DE69229552D1 (de) 1999-08-12
ATE181925T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
HU9303314D0 (en) Process for producing elasteze- and catepsin-d-inhibitors
GR3034208T3 (en) Human neutrophil elastase inhibitors
MY122696A (en) Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases.
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
FI922434A0 (fi) Produktion av rekombinant human interleukin-1-inhibitor.
CA2076307A1 (en) Orally-active elastase inhibitors
DE69312793D1 (de) Gesockelte Hochdruckentladungslampe
ATE199090T1 (de) Gegenüber eigenen inhibitoren resistente t-pa mutanten
DE69009260D1 (de) Wassergekühlte Niederdruckgasentladungslampe.
MX9801190A (es) Inhibidores de prolil endopeptidasa.
CA2189527A1 (en) Novel Elastase Inhibitors
BG102663A (en) Method for the purification of thrombino-like proteases from snake poison
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
CA2109516A1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
FR2707464B1 (fr) Perfectionnement aux articles chaussants.
ITRM940253A0 (it) "procedimento per la produzione di policarbonato".
ZA932443B (en) The purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography.
KR950004736U (ko) 슬러리 공정의 세정챔버
MX9606031A (es) Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos.
ITRM930021A0 (it) Procedimento di trattamento di lastre di trachite vetusia.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee